 "Sanofi India net profit at Rs 530 crore in September quarter")
Drugmaker Sanofi India on Tuesday reported a net profit of Rs 529.8 crore for the third quarter ended September 30, aided by Rs 489.2 crore gain from the sale of its nutraceuticals business.
The company had reported a net profit of Rs 132.9 crore in the July-September quarter of the previous fiscal, Sanofi India said in a regulatory filing.
Sanofi India board in its meeting held on July 27 had approved a transaction for slump sale and transfer of its nutraceuticals business to Universal Nutriscience for a consideration of Rs 587 crore.
The transaction was closed on September 27.
During the period under review, the company has accounted for a gain of Rs 489.2 crore from the transaction, which was disclosed as an exceptional item.
The company's revenue from operations rose to Rs 754.5 crore as compared to Rs 686.6 crore in the year-ago period.
Sanofi follows a January-December financial year.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app